AJANTA PHARMA
Back to Income Statement
|
AJANTA PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹4,648 Cr | ₹4,209 Cr | ₹3,743 Cr | ₹3,341 Cr | ₹2,890 Cr |
What is the latest Revenue of AJANTA PHARMA ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹4,648 Cr |
| Mar2025 | ₹4,209 Cr |
| Mar2024 | ₹3,743 Cr |
| Mar2023 | ₹3,341 Cr |
| Mar2022 | ₹2,890 Cr |
How is Revenue of AJANTA PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,648 Cr | 10.44 | |
| Mar2025 | ₹4,209 Cr | 12.45 | |
| Mar2024 | ₹3,743 Cr | 12.02 | |
| Mar2023 | ₹3,341 Cr | 15.62 | |
| Mar2022 | ₹2,890 Cr | - | |
Compare Revenue of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹42,106.3 Cr | -1.5% | 14.4% | 31.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,005.0 Cr | 2.7% | 7.5% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,867.0 Cr | 4.2% | 3.9% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹163,246.0 Cr | 4.3% | 11.2% | 42.5% | Stock Analytics | |
| CIPLA | ₹118,854.0 Cr | 0.4% | 5.3% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,246.0 Cr | 0.9% | 8% | 5.6% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | -1.5% |
14.4% |
31.7% |
| SENSEX | 2% |
5.3% |
-6.5% |
You may also like the below Video Courses